---
title: "Unity Biotechnology (UBX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/UBX.US.md"
symbol: "UBX.US"
name: "Unity Biotechnology"
industry: "Biotechnology"
datetime: "2026-05-20T11:26:47.259Z"
locales:
  - [en](https://longbridge.com/en/quote/UBX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/UBX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/UBX.US.md)
---

# Unity Biotechnology (UBX.US)

## Company Overview

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. Its lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. The company also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, an a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.13 | 93 | - | - | - |
| PB | -16.80 | 592 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/UBX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/UBX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/UBX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/UBX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**